Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours Β· Estimated delivery Oct 20 - Oct 25
The clash over compounded GLP-1 medications comes as a new survey of primary care physicians finds that doctors are increasingly concerned about the risks of patients using third-party telehealth prescribers of GLP-1s for weight loss
Youve heard of the popular glucagon-like peptide-1 (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound)
GLP-1 medications work by mimicking the effects of this hormone, leading to various beneficial outcomes for individuals with Type 2 diabetes and those struggling with obesity
Three common failure modes and the fixes: Boredom from eating the same meals every day
Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery
